BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 18005504)

  • 1. The incidence of pelvic inflammatory disease in untreated women infected with Chlamydia trachomatis: a structured review.
    Risser WL; Risser JM
    Int J STD AIDS; 2007 Nov; 18(11):727-31. PubMed ID: 18005504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up.
    Morré SA; van den Brule AJ; Rozendaal L; Boeke AJ; Voorhorst FJ; de Blok S; Meijer CJ
    Int J STD AIDS; 2002 Dec; 13 Suppl 2():12-8. PubMed ID: 12537719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of sequelae after Chlamydia trachomatis genital infection in women.
    Haggerty CL; Gottlieb SL; Taylor BD; Low N; Xu F; Ness RB
    J Infect Dis; 2010 Jun; 201 Suppl 2():S134-55. PubMed ID: 20470050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses.
    van Valkengoed IG; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ
    Int J Epidemiol; 2004 Apr; 33(2):416-25. PubMed ID: 15082651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of pelvic inflammatory disease in untreated women infected with Chlamydia trachomatis.
    Aghaizu A; Atherton H; Mallinson H; Simms I; Kerry S; Oakeshott P; Hay PE
    Int J STD AIDS; 2008 Apr; 19(4):283. PubMed ID: 18482953
    [No Abstract]   [Full Text] [Related]  

  • 6. Subsequent sexually transmitted infection after outpatient treatment of pelvic inflammatory disease.
    Trent M; Chung SE; Forrest L; Ellen JM
    Arch Pediatr Adolesc Med; 2008 Nov; 162(11):1022-5. PubMed ID: 18981349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening.
    Land JA; Van Bergen JE; Morré SA; Postma MJ
    Hum Reprod Update; 2010; 16(2):189-204. PubMed ID: 19828674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Chlamydia trachomatis in women with PID: effectiveness of therapy.
    De Punzio C; Neri E; Guazzelli G; Gremigni R
    Acta Eur Fertil; 1995; 26(4):149-51. PubMed ID: 9098478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Has the incidence of pelvic inflammatory disease following chlamydial infection been overestimated?
    Simms I; Horner P
    Int J STD AIDS; 2008 Apr; 19(4):285-6. PubMed ID: 18482954
    [No Abstract]   [Full Text] [Related]  

  • 10. Douching, pelvic inflammatory disease, and incident gonococcal and chlamydial genital infection in a cohort of high-risk women.
    Ness RB; Hillier SL; Kip KE; Richter HE; Soper DE; Stamm CA; McGregor JA; Bass DC; Rice P; Sweet RL
    Am J Epidemiol; 2005 Jan; 161(2):186-95. PubMed ID: 15632269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection.
    Scholes D; Stergachis A; Heidrich FE; Andrilla H; Holmes KK; Stamm WE
    N Engl J Med; 1996 May; 334(21):1362-6. PubMed ID: 8614421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of Chlamydia trachomatis in patients with pelvic inflammatory disease.
    Ravindran J; Tan YI; Ngeow YF
    Med J Malaysia; 1998 Mar; 53(1):16-21. PubMed ID: 10968132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.
    Gift TL; Gaydos CA; Kent CK; Marrazzo JM; Rietmeijer CA; Schillinger JA; Dunne EF
    Sex Transm Dis; 2008 Nov; 35(11 Suppl):S66-75. PubMed ID: 18830137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia trachomatis in pelvic inflammatory disease.
    Shrikhande SN; Joshi SG; Zodpey SP; Saoji AM
    Indian J Pathol Microbiol; 1995 Apr; 38(2):181-4. PubMed ID: 8919106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a cluster-randomized 1-year follow-up study.
    Ostergaard L; Andersen B; Møller JK; Olesen F
    Clin Infect Dis; 2000 Oct; 31(4):951-7. PubMed ID: 11049776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chlamydia trachomatis infection in men and its association with gynecologic alterations in their sexual partners].
    Guerra-Infante FM; Tapia-Yáñez JR; López-Hurtado M; Flores-Medina S; Díaz-García FJ
    Rev Invest Clin; 2005; 57(3):406-14. PubMed ID: 16187700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectopic pregnancy and pelvic inflammatory disease: a renewed epidemic?
    Mol F; van Mello NM; Mol BW; van der Veen F; Ankum WM; Hajenius PJ
    Eur J Obstet Gynecol Reprod Biol; 2010 Aug; 151(2):163-7. PubMed ID: 20472335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of cervical Chlamydia trachomatis infection in postabortal pelvic inflammatory disease.
    Westergaard L; Philipsen T; Scheibel J
    Obstet Gynecol; 1982 Sep; 60(3):322-5. PubMed ID: 7121913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical manifestations and epidemiology of the new genetic variant of Chlamydia trachomatis.
    Bjartling C; Osser S; Johnsson A; Persson K
    Sex Transm Dis; 2009 Sep; 36(9):529-35. PubMed ID: 19617866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early screening for Chlamydia trachomatis in young women for primary prevention of pelvic inflammatory disease (i-Predict): study protocol for a randomised controlled trial.
    Tamarelle J; Thiébaut ACM; Sabin B; Bébéar C; Judlin P; Fauconnier A; Rahib D; Méaude-Roufai L; Ravel J; Morré SA; de Barbeyrac B; Delarocque-Astagneau E;
    Trials; 2017 Nov; 18(1):534. PubMed ID: 29132441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.